Haemonetics Corp. (HAE) Misses Q2 EPS Views; Affirms Outlook
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.53 --0%
EPS Growth %: -0.9%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: -0.9%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.65, $0.13 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $170.6 million versus the consensus estimate of $170.4 million.
Affirms outlook.
Affirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Nucor guides Q2 2026 earnings to $4.70-$4.80 per diluted share
- Jabil beats consensus estimates but shares dip
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
